<DOC>
	<DOCNO>NCT00922766</DOCNO>
	<brief_summary>To collect data safety effectiveness dalteparin management non-ST segment elevate acute coronary syndrome nurse home patient treat conservatively ( without percutaneous corornary intervention [ PCI ] coronary artery bypass graft [ CABG ] within 48 hour ) .</brief_summary>
	<brief_title>Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Dalteparin</mesh_term>
	<mesh_term>Heparin , Low-Molecular-Weight</mesh_term>
	<criteria>Male female patient 18 year present chest pain potentially eligible inclusion study satisfy criterion unstable coronary artery disease per investigator 's routine practice receive least one injection Fragmin ( dalteparin sodium ) part routine clinical practice expect treat conservatively ( without PCI CABG within 48 hour ) index hospitalization . Evidence personally sign date informed consent document indicate subject ( legally acceptable representative ) inform pertinent aspect study . Patients contraindicate receive agent per local approve prescribe information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>dalteparin non-ST segment elevate acute coronary syndrome</keyword>
</DOC>